The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina

H A B Vermeer, H Rashid, M D Esajas, J M Oldhoff*, B Horváth

*Bijbehorende auteur voor dit werk

Onderzoeksoutput: LetterAcademicpeer review

3 Citaten (Scopus)
89 Downloads (Pure)


Erosive lichen planus affecting the vulva and vagina (ELPV) is a rare inflammatory skin disease, presenting with painful erosions and severe scarring.1 The disease course is persistent and often refractory to treatment: up to 45% patients do not experience remission with topical treatments, while evidence for systemic treatments remains scarce.2 Hydroxychloroquine (HCQ) is frequently used in daily practice as a first choice systemic therapy.3 However, little evidence is available on HCQ for ELPV.2 The aim of this study was to analyse the effectiveness and safety of HCQ in ELPV.

Originele taal-2English
Aantal pagina's2
TijdschriftThe British journal of dermatology
Vroegere onlinedatum6-feb.-2021
StatusPublished - 23-mrt.-2021

Citeer dit